Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
A Citigroup downgrade to Sell, a put/call ratio at a two-standard-deviation extreme, and a borrow market that remains acutely tight have converged on PS within the same week. Each signal points the same direction.
Citigroup's Matthew Heimermann downgraded Pershing Square to Sell on October 9, maintaining a $45 target. The stock closed at $54.59, putting the target 17.5% below the current price. This is Heimermann's second cut in two months: he moved from Buy to Neutral in August, then from Neutral to Sell last Thursday.
The bear case centres on NAV erosion and valuation. PSH NAV fell to $76.93 from $81.96 between late August and late September. PSUS still trades at a 20.1% discount to NAV. The stock now trades at 41.2x forward fee-related earnings against a peer median of 19.9x. Jones Trading also downgraded to Hold in late September, and the consensus has shifted to a 7-Hold, 2-Sell split with no Buy ratings remaining.
The bull side points to permanent capital, 82.4% FRE margins, and 31% sequential growth in fee-paying AUM to $22.3 billion. That case is real. The problem is that the stock has already re-rated sharply: PS is up 31% over the past month, a move that has outrun most of the near-term fundamental catalysts.
Put/call ratio hit 2.00 on October 9, the highest since August. That is 2.1 standard deviations above the 20-day mean of 1.31. Options traders are buying downside protection at a rate that confirms the directional bet the analyst community is making with ratings.
The borrow market corroborates. Availability sits at roughly 12%, meaning only one share in eight in the lending pool remains unborrowed. Cost to borrow is 239% annualised. As recently as September 16, it was 33%. That is not a gradual drift: it is a near-vertical repricing of short-side demand over five weeks. The ORTEX short score holds at 65.9, consistent with readings from the past two weeks, a level that flags sustained composite pressure from lending, positioning, and momentum signals.
One structural note worth watching: ORTEX forecasts a 68% probability of PS joining the Russell 1000 at the December 2026 Semi-Annual Review. The rank date is October 30, with an announcement expected November 13 and a trade date of December 11. That would require index trackers to buy an estimated $112 million of stock, equivalent to 5.6 days of normal volume. Among the 120 comparable past additions, the median move from announcement to effective date was minus 3.6%, with only 32% moving in the expected direction. A forecast is not an announcement, and history here is not encouraging for momentum.
See the live data behind this article on ORTEX.
Open PS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
